Local Anesthetic Clinical Trial

Part of paid clinical trials in Dallas, Texas.

Sponsor
Baylor Research Institute
Study ID
NCT07601750
Phase
PHASE4
Status
Enrolling By Invitation

Conditions

  • Anesthesia, Local
  • Mohs Micrographic Surgery

Eligibility Criteria

Sex
ALL
Age
18 Years - 89 Years
Healthy Volunteers
Not accepted

Interventions

  • Lidocaine — DRUG
    Standard of Care drug
  • Bupivacaine Hydrochloride — DRUG
    Study Drug
  • Mepivacaine Hydrochloride — DRUG
    Study Drug
  • Chlorprocaine — DRUG
    Study Drug

Study Details

To compare several local anesthetics when used during dermatological surgery.

Key Dates

Start date
Jan 7, 2025
Status verified
May 2026
Primary completion
Dec 31, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
400 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Treatment Group
    Anesthetics including, bupivacaine, mepivacaine, chlorprocaine
  • Active Comparator: Standard of Care Group

Primary Outcome Measure

Determine if pain increases with local injections at each stage of surgery. [ Time Frame: 5 mins, 15 mins, 20 mins, 25 mins, 30 mins, 45 mins (reconstruction) ]

Locations (1)

FacilityCityStateZIPSite coordinators
Baylor University Medical CenterDallasTexas75246-

Find similar trials in Dallas, TX

By research site
Baylor University Medical Center· Dallas, TX

Related Studies